YU44687B - Process for making alive purified vaccine for marek's disseases - Google Patents

Process for making alive purified vaccine for marek's disseases

Info

Publication number
YU44687B
YU44687B YU599/85A YU59985A YU44687B YU 44687 B YU44687 B YU 44687B YU 599/85 A YU599/85 A YU 599/85A YU 59985 A YU59985 A YU 59985A YU 44687 B YU44687 B YU 44687B
Authority
YU
Yugoslavia
Prior art keywords
marek
disease
virus
mdv
vaccine
Prior art date
Application number
YU599/85A
Other languages
English (en)
Other versions
YU59985A (en
Inventor
Boer G F De
Original Assignee
Central Diergeneeskundig Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Diergeneeskundig Inst filed Critical Central Diergeneeskundig Inst
Publication of YU59985A publication Critical patent/YU59985A/xx
Publication of YU44687B publication Critical patent/YU44687B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU599/85A 1984-04-09 1985-04-09 Process for making alive purified vaccine for marek's disseases YU44687B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (2)

Publication Number Publication Date
YU59985A YU59985A (en) 1988-06-30
YU44687B true YU44687B (en) 1990-12-31

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
YU599/85A YU44687B (en) 1984-04-09 1985-04-09 Process for making alive purified vaccine for marek's disseases

Country Status (17)

Country Link
US (1) US4673572A (nl)
EP (1) EP0159743B1 (nl)
JP (1) JPS6123A (nl)
AT (1) ATE56364T1 (nl)
AU (1) AU574164B2 (nl)
CA (1) CA1251397A (nl)
DD (1) DD232822A5 (nl)
DE (1) DE3579617D1 (nl)
ES (1) ES8605680A1 (nl)
HU (1) HU194496B (nl)
IL (1) IL74809A (nl)
IN (1) IN163229B (nl)
MX (1) MX7718E (nl)
NL (1) NL8401120A (nl)
WO (1) WO1985004588A1 (nl)
YU (1) YU44687B (nl)
ZA (1) ZA852564B (nl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0748867A1 (en) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek's disease vaccine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
AU725959B2 (en) * 1996-06-04 2000-10-26 University Of Georgia Research Foundation, Inc., The Modified live avian polyomavirus vaccine in psittacine birds
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
BR112014023398A8 (pt) 2012-03-22 2022-08-16 Merial Ltd Vírus da doença de marek modidicado e vacinas feitas do mesmo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
IL74809A (en) 1990-09-17
IN163229B (nl) 1988-08-27
DE3579617D1 (de) 1990-10-18
AU574164B2 (en) 1988-06-30
HUT38542A (en) 1986-06-30
IL74809A0 (en) 1985-07-31
HU194496B (en) 1988-02-29
JPS6123A (ja) 1986-01-06
ATE56364T1 (de) 1990-09-15
JPH0317808B2 (nl) 1991-03-11
EP0159743B1 (en) 1990-09-12
DD232822A5 (de) 1986-02-12
WO1985004588A1 (en) 1985-10-24
ES8605680A1 (es) 1986-04-16
ZA852564B (en) 1985-11-27
NL8401120A (nl) 1985-11-01
EP0159743A1 (en) 1985-10-30
YU59985A (en) 1988-06-30
US4673572A (en) 1987-06-16
MX7718E (es) 1990-10-10
ES541930A0 (es) 1986-04-16
CA1251397A (en) 1989-03-21
AU4156185A (en) 1985-11-01

Similar Documents

Publication Publication Date Title
YU44687B (en) Process for making alive purified vaccine for marek's disseases
ES8502871A1 (es) Procedimiento de obtencion de vacunas de bronquitis infecciosa para aves de corral
EP0125245B1 (en) Propagation of hemorrhagic enteritis virus in a turkey cell line
Purchase Prevention of Marek's disease: a review
ES8200227A1 (es) Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral
US4895717A (en) Revertant serotype 1 Marek's disease vaccine
CA2185407A1 (en) Sustainable chick cell line infected with marek's disease virus
US5686287A (en) Marek's disease virus vaccine
US4895718A (en) Serotype 2 Marek's disease vaccine
US5149530A (en) Live newcastle disease virus vaccines
Carmichael et al. Small-plaque variant of canine herpesvirus with reduced pathogenicity for newborn pups
US4213965A (en) Small-plaque variant canine herpesvirus vaccine
CA2112225C (en) Attenuated revertant serotype 1 marek's disease vaccine
US5565202A (en) Low enhancement serotype 2 vaccine for marek's disease
Jeffries et al. Atypical menaquinone pattern in a strain of Staphylococcus aureus
Allison Tumour Viruses: Are Observations on Tumour Viruses in Animals Applicable to Man?
El‐Zein et al. Preparation and testing of a goat pox vaccine from a pathogenic field isolate attenuated in cell culture
EP0703294A1 (en) Marek's disease virus vaccine
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
CA1289881C (en) Vaccine against herpes simplex
SU1707075A1 (ru) Штамм вируса болезни Марека дл изготовлени вакцины против болезни Марека
Hirai et al. Genomic difference of herpesvirus of turkeys at low and high passage levels in culture of O1 and FC126 strains
KR960016906A (ko) 약독화 수두 생바이러스 백신 및 그의 제조방법
RO96364B1 (ro) PROCEDEU DE PREPARARE A UNUI VACCIN VIU PURIFICAT îMPOTRIVA BOLII LUI MAREK